ViiV Healthcare Overview
- Founded
- 2009
- Status
- Private
- Employees
- 700
- Latest Deal Type
- 2ndary - Private
- Financing Rounds
- 2
- Investments
- 1
ViiV Healthcare General Information
Description
Operator of a global specialist HIV company intended to deliver innovative new options for the care and treatment of people living with HIV/AIDS. The company's products include dolutegravir, zidovudine, fosamprenavi, maraviroc, abacavir, and nelfinavir and delavirdine mesylate and provides nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitor, protease inhibitors, and CCR5 antagonist for the treatment of AIDS.
Contact Information
Website
Formerly Known As
GlaxoSmithKline Newco Limited
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors/Wholesale
Other Industries
Drug Discovery
Biotechnology
Other Healthcare
Primary Office
- 980 Great West Road
- Brentford TW8 9GS
- England, United Kingdom
+44 020 0000 0000
ViiV Healthcare Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore ViiV Healthcare‘s full profile, request access.
Request a free trialViiV Healthcare Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a global specialist HIV company intended to deliver innovative new options for the care and treatment of peo
Distributors/Wholesale
Brentford, United Kingdom
700
As of 2017
00000000000
00000000
nsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut eni
0000000000000
Abingdon, United Kingdom
000
As of 0000
00000
00000000000
00000
0000000
dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
0000 000000000
Bothell, WA
0000
As of 0000
00.000
000000000
00.000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialViiV Healthcare Competitors (26)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immunocore | Venture Capital-Backed | Abingdon, United Kingdom | 000 | 00000 | 00000000000 | 00000 |
| 0000000 00000000 | Formerly VC-backed | Bothell, WA | 0000 | 00.000 | 000000000 | 00.000 |
| 000000 | Formerly VC-backed | Lyon, France | 000 | 000.00 | 00000000 | 000.00 |
| 00000000 00000 | Formerly VC-backed | Leiden, Netherlands | 000 | 00000 | 000000000 | 00000 |
| 000000 000000 | Formerly VC-backed | Marseille, France | 000 | 00000 | 000000000 | 00000 |
ViiV Healthcare Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Deborah Waterhouse | Chief Executive Officer | ||
| Andries Jerome | Chief Financial Officer | ||
| John Pottage Jr. | Senior Vice President and Chief Scientific and Medical Officer |
ViiV Healthcare Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialViiV Healthcare Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore ViiV Healthcare‘s full profile, request access.
Request a free trialViiV Healthcare Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000-00000 0000 | 22-Feb-2016 | 000000000 00000 00 | 000 | Buildings and Property | 000000000 00000 |